Savvy Updates, 2/4/19: Plant Hallucinogen, Afrezza Bluetooth Inhaler, Senseonics & MRI, Vitamin D Levels
Plant Hallucinogen Holds Hope for Diabetes Treatment was reported by Emily Willingham for Scientific American, 21 December 2018. A potent molecular cocktail containing a compound from ayahuasca spurs rapid growth of insulin-producing cells – oooh,...
Savvy Updates, 11/12/18: Prevalence of Diabetes, Novo & Flex, Metformin and T1, New T1d Drug, Machine Learning, Insulin Trigger
Estimated Prevalence of Diabetes in the United States was reported on EndocrinologyAdvisor.com, 24 September, 2018 … and the numbers are staggering! The prevalence of type 1 and type 2 diabetes is 0.5 and 8.5 percent, respectively, among U.S. adults, according...
Savvy Updates: BCG Vaccine, Glucobeam, Lilly’s Encapsulation, Lifescan, iPro2
BCG vaccine can reverse Type 1 diabetes to almost undetectable levels, eight-year study shows was all over the news this past week, on Telegraph.co.uk/Science, 21 June 2018, as well as KCRA3 News, Boston. New research out of Massachusetts General Hospital finds...
Savvy News from UC Irvine (CA)
Oooooh, lots of research, lots of patent applications. Laser Associated Sciences Technology Plans to Improve Hemodynamic Monitoring Huh? I know, it’s complicated. It all started at the Beckman Laser Institute with a trio of colleagues who,...
Savvy Updates 10 April 2018 FOLLOW THE $$: Lilly in our Future, JDRF Early Stage Investment Fund, New Infusion Technology
Eli Lilly ponies up $63M for Sigilon’s diabetes cell therapies, according to Amirah Al Adrus of FierceBiotech.com, 4 April 2018. Eli Lilly is continuing its push into new diabetes products, paying $63 million up front to get its hands on Sigilon Therapeutics’...
More Diabetes Blogs